R
Rudolph M. Navari
Researcher at University of Alabama at Birmingham
Publications - 175
Citations - 7558
Rudolph M. Navari is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Chemotherapy-induced nausea and vomiting & Nausea. The author has an hindex of 44, co-authored 172 publications receiving 6841 citations. Previous affiliations of Rudolph M. Navari include World Health Organization & VCU Medical Center.
Papers
More filters
Journal ArticleDOI
Responses of cerebral arteries and arterioles to acute hypotension and hypertension
Hermes A. Kontos,E. P. Wei,Rudolph M. Navari,Joseph E. Levasseur,William I. Rosenblum,Jr Jl Patterson +5 more
TL;DR: The responses of cerebral precapillary vessels to changes in arterial blood pressure were studied in anesthetized cats equipped with cranial windows for the direct observation of the pial microcirculation of the parietal cortex and found to be size dependent.
Journal ArticleDOI
Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist
Rudolph M. Navari,Rick R. Reinhardt,Richard J. Gralla,Mark G. Kris,Paul J. Hesketh,Ali Khojasteh,Hedy L. Kindler,Thomas H. Grote,Kelly Pendergrass,Steven M. Grunberg,Alexandra D. Carides,Barry J. Gertz +11 more
TL;DR: The neurokinin-1-receptor antagonist L-754,030 prevents delayed emesis after treatment with cisplatin and combined with granisetron plus dexamethasone improves the prevention of acute emesis.
Journal ArticleDOI
Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats.
TL;DR: The results show that the vascular lesions in the pial microcirculation following this type of brain injury are due to the rise in arterial pressure.
Journal ArticleDOI
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari,Rui Qin,Kathryn J. Ruddy,Heshan Liu,Steven F. Powell,Madhuri Bajaj,Leah L. Dietrich,David D. Biggs,Jacqueline M. Lafky,Charles L. Loprinzi +9 more
TL;DR: In this paper, the authors compared olanzapine with placebo, in combination with dexamethasone, aprepitant or fosaprepitant, and a 5-hydroxytryptamine type 3-receptor antagonist, in patients with no previous chemotherapy who were receiving cisplatin (≥70 mg per square meter of body-surface area) or cyclophosphamide-doxorubicin.
Journal ArticleDOI
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari,Matti S. Aapro +1 more
TL;DR: The most effective regimens and how they work are reviewed and the most important changes in cancer treatment in recent decades are reviewed.